SCHEMBL8901400

SCHEMBL8901400

O=C(O)c1ccc(/C=C/c2cccc(C(=O)O)c2)cc1

nearest known ligand 0.80

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TTR P02766 5/20 0.80
UNG P13051 1/20 0.63
FBP1 P09467 1/20 0.60
SRD5A1 P18405 1/20 0.59
SRD5A2 P31213 1/20 0.59
P4HB P07237 3/20 0.57
HDAC1 Q13547 1/20 0.52
PTPN1 P18031 2/20 0.51
HNF4A P41235 1/20 0.51
RARA P10276 1/20 0.51
RARB P10826 1/20 0.51
RARG P13631 1/20 0.51
TRIM24 O15164 1/20 0.50
TRIM33 Q9UPN9 1/20 0.50
PTPN12 Q05209 1/20 0.50
PTPN22 Q9Y2R2 1/20 0.50
ALDH1A1 P00352 1/20 0.50
PPARG P37231 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8899997 1.00 TTR (0.80) TTRUNGFBP1SRD5A1SRD5A2
SCHEMBL9095165 1.00 TTR (0.80) TTRUNGFBP1SRD5A1SRD5A2
SCHEMBL13926057 0.96 TTR (0.86) TTRUNGFBP1SRD5A1SRD5A2
SCHEMBL5020598 0.92 TTR (0.79) TTRUNGFBP1SRD5A1SRD5A2
SCHEMBL29759512 0.92 TTR (0.79) TTRUNGFBP1SRD5A1SRD5A2
SCHEMBL1927537 0.92 TTR (0.79) TTRUNGFBP1SRD5A1SRD5A2
SCHEMBL31317645 0.92 TTR (0.79) TTRUNGFBP1SRD5A1SRD5A2
SCHEMBL1927539 0.92 TTR (0.79) TTRUNGFBP1SRD5A1SRD5A2
SCHEMBL9075299 0.92 TTR (0.79) TTRUNGFBP1SRD5A1SRD5A2
SCHEMBL808972 0.92 TTR (0.79) TTRUNGFBP1SRD5A1SRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0663391-B1 Sulphuric acid esters of sugar alcohols for the treatment of arteriosclerotic changes in the vascular walls HOFFMANN LA ROCHE (CH) 1997-04-09 EP disclosed
US-5521160-A COMPOUNDS FOR TREATMENT OF ATHERIOSCLEROSIS IN BLOOD VESSELS AND PREVENTION OF RESTENOSIS AFTER ANGIOPLASTY HOFFMANN-LA ROCHE INC. (US) 1996-05-28 US disclosed
EP-0663391-A1 Sulphuric acid esters of sugar alcohols for the treatment of arteriosclerotic changes in the vascular walls F. HOFFMANN-LA ROCHE AG (CH) 1995-07-19 EP disclosed
US-4654412-A UNSATURATED MONOMERS, FIBERS, FILMS, MOLDINGS CELANESE CORPORATION (US) 1987-03-31 US disclosed
US-4526822-A Oxygen impermeability EASTMAN KODAK COMPANY (US) 1985-07-02 US disclosed